Kuriyel Ralf
Senior Vice President at RGEN
- Sold, on record
- $10.6M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Aug 2, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RGENREPLIGEN CORPSenior Vice President
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale RGENPlan not statedAug 30, 2021 2021
Sold 4,001 shares at $282.13 ($1.1M)
Kuriyel Ralf, Senior VP, R&D
Sold 18.7% of holdings ($6M position)17,354 shares left1.6x usual sizeFiling
- 2 Form 4 sale RGENPlan not statedAug 11, 2022 +346 days
Sold 4,840 shares at $254.32 ($1.2M)
Kuriyel Ralf, Senior VP, R&D
Sold 20.1% of holdings ($6.1M position)19,270 shares left1.6x usual sizeFiling
- 3 Form 144 notice RGENNoticeMar 11, 2024 +578 days
Filed to sell 3,517 shares ($681k)
Kuriyel Ralf, Officer
No 10b5-1 planFiling
- 4 Form 4 sale RGENNo planMar 11, 2024 same day
Sold 3,517 shares at $193.73 ($681k)
Kuriyel Ralf, Senior VP, R&D
No 10b5-1 planSold 12.7% of holdings ($5.4M position)24,260 shares leftFollows a Form 144Filing
- 5 Form 144 notice RGENNoticeAug 1, 2024 +143 days
Filed to sell 4,465 shares ($740k)
Kuriyel Ralf, Senior Vice President
No 10b5-1 planFiling
- 6 Form 4 sale RGENNo planAug 1, 2024 same day
Sold 4,465 shares at $165.67 ($740k)
Kuriyel Ralf, Senior VP, R&D
No 10b5-1 planSold 18.8% of holdings ($3.9M position)19,261 shares leftFollows a Form 144Filing
- 7 Form 144 notice RGENNoticeAug 2, 2024 +1 day
Filed to sell 7,148 shares ($1.1M)
Kuriyel Ralf, Senior Vice President
No 10b5-1 plan1.6x usual sizeFiling
- 8 Form 4 sale RGENUnusualAug 2, 2024 same day
Sold 7,148 shares at $159.35 ($1.1M)
Kuriyel Ralf, Senior VP, R&D
No 10b5-1 planSold 36.8% of holdings ($3.1M position)12,288 shares left1.6x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2024 | Aug 5, 2024 | RGEN | Senior VP, R&D | Form 4 sale | 7,148 | $1.1M | 36.8% | Unusual | SEC |
| Aug 2, 2024 | Aug 2, 2024 | RGEN | Senior Vice President | Form 144 notice | 7,148 | $1.1M | Notice | SEC | |
| Aug 1, 2024 | Aug 1, 2024 | RGEN | Senior VP, R&D | Form 4 sale | 4,465 | $740k | 18.8% | No plan | SEC |
| Aug 1, 2024 | Aug 1, 2024 | RGEN | Senior Vice President | Form 144 notice | 4,465 | $740k | Notice | SEC | |
| Mar 11, 2024 | Mar 12, 2024 | RGEN | Senior VP, R&D | Form 4 sale | 3,517 | $681k | 12.7% | No plan | SEC |
| Mar 11, 2024 | Mar 11, 2024 | RGEN | Officer | Form 144 notice | 3,517 | $681k | Notice | SEC | |
| Aug 11, 2022 | Aug 12, 2022 | RGEN | Senior VP, R&D | Form 4 sale | 4,840 | $1.2M | 20.1% | Plan not stated | SEC |
| Aug 30, 2021 | Sep 2, 2021 | RGEN | Senior VP, R&D | Form 4 sale | 4,001 | $1.1M | 18.7% | Plan not stated | SEC |
| Jun 10, 2021 | Jun 14, 2021 | RGEN | Senior VP, R&D | Form 4 sale | 6,802 | $1.3M | 24.2% | Unusual | SEC |
| May 14, 2021 | May 18, 2021 | RGEN | Senior VP, R&D | Form 4 sale | 710 | $122k | 2.8% | Plan not stated | SEC |
| Mar 10, 2021 | Mar 12, 2021 | RGEN | Senior VP, R&D | Form 4 sale | 8,000 | $1.5M | 24.0% | Unusual | SEC |
| Mar 4, 2021 | Mar 8, 2021 | RGEN | Senior VP, R&D | Form 4 sale | 2,075 | $398k | 7.6% | Plan not stated | SEC |
| Dec 16, 2020 | Dec 18, 2020 | RGEN | Senior VP, R&D | Form 4 sale | 435 | $81k | 1.7% | Plan not stated | SEC |
| Aug 6, 2020 | Aug 10, 2020 | RGEN | Senior VP, R&D | Form 4 sale | 5,000 | $769k | 16.1% | Unusual | SEC |
| May 15, 2020 | May 19, 2020 | RGEN | Senior VP, R&D | Form 4 sale | 435 | $61k | 1.6% | Plan not stated | SEC |
| May 13, 2020 | May 15, 2020 | RGEN | Senior VP, R&D | Form 4 sale | 8,000 | $1M | 23.2% | Unusual | SEC |
| Mar 4, 2020 | Mar 5, 2020 | RGEN | Senior VP, R&D | Form 4 sale | 3,005 | $272k | 10.2% | Unusual | SEC |
| Feb 26, 2020 | Feb 27, 2020 | RGEN | Senior VP, R&D | Form 4 sale | 195 | $17k | 0.7% | Plan not stated | SEC |
| Mar 5, 2019 | Mar 5, 2019 | RGEN | Senior VP, R&D | Form 4 sale | 2,240 | $131k | 10.6% | Plan not stated | SEC |
| Feb 28, 2019 | Mar 4, 2019 | RGEN | Senior VP, R&D | Form 4 sale | 185 | $11k | 1.1% | Plan not stated | SEC |
| Dec 18, 2018 | Dec 20, 2018 | RGEN | Senior VP, R&D | Form 4 sale | 311 | $17k | 2.5% | Plan not stated | SEC |